Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 28 of the 28 references it cites were found in a registry or an index.

Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews

Whelan, Kevin · 2011 · Current Opinion in Clinical Nutrition and Metabolic Care

Abstract

PURPOSE OF REVIEW: Irritable bowel syndrome (IBS) is a common disorder of the gastrointestinal tract, about which there has been considerable recent research. The aim of this article is to briefly review the aspects of IBS pathogenesis that involve the gastrointestinal microbiota, and then to critically appraise the recent and emerging evidence for the use of probiotics and prebiotics in its management. RECENT FINDINGS: The increased risk of developing IBS following gastroenteritis and the co-existence of dysbiosis, elevated luminal gas production and immune activation, indicate that the gastrointestinal microbiota may be a therapeutic target in IBS. Most systematic reviews indicate that probiotics have a beneficial impact on global IBS symptoms, abdominal pain and flatulence. However, recent trials indicate that different probiotics can improve, have no effect, or even worsen symptoms, confirming that benefits are likely to be strain and symptom-specific. There are no recent clinical trials of prebiotics in IBS, although previous studies indicate potential benefit at lower doses. SUMMARY: Clearly, some probiotics have considerable potential in the management of IBS; however, the benefits are likely to be strain-specific. Preliminary studies suggest low doses of prebiotics may improve symptoms of IBS, although further robust clinical trials are required.

Overview

Integrity signals

Registry

Crossref · 10.1097/mco.0b013e32834b8082

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Research works printed but not linked: 3

  1. Spiller, 2010, epatol, 8, 125
  2. Pimentel, 364, N Engl J Med, 22-, 32
  3. Huertas-Ceballos, 2009, Cochrane Database Syst Rev, 1, CD003019

Cited by

See all 120

Metadata

Authors
Whelan, K.
Affiliations
King's College London (GB)
Corresponding author
Whelan, Kevin
Venue
Current Opinion in Clinical Nutrition and Metabolic Care
Published
2011-11
Volume
14
Issue
6
Pages
581-587
ISSN
1363-1950 (ISSN-L)
OpenAlex
W2001298761
Cited by
120
References
28
Citations by year
2025: 3 · 2024: 1 · 2023: 8 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 12 · 2015: 14 · 2014: 21 · 2013: 20 · 2012: 11
FWCI
2.79
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Clinical Nutrition & Metabolic Care (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
irritable bowel syndrome, probiotics, prebiotics, gut microbiota, dysbiosis, IBS pathogenesis, strain-specific effects, abdominal pain, flatulence, gastroenteritis, immune activation
MeSH terms
Systematic Reviews as Topic, Dose-Response Relationship, Drug, Flatulence, Humans, Meta-Analysis as Topic, Abdominal Pain, Randomized Controlled Trials as Topic, Probiotics, Gastrointestinal Tract, Irritable Bowel Syndrome, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. https://app.cochat.ai/papers/10.1097/mco.0b013e32834b8082
The paper
Whelan, K. (2011). Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Current Opinion in Clinical Nutrition and Metabolic Care. https://doi.org/10.1097/mco.0b013e32834b8082

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.